BUONTEMPO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.846
AS - Asia 2.258
EU - Europa 1.774
AF - Africa 166
SA - Sud America 96
OC - Oceania 3
Totale 7.143
Nazione #
US - Stati Uniti d'America 2.826
SG - Singapore 640
VN - Vietnam 634
CN - Cina 527
GB - Regno Unito 432
IT - Italia 312
SE - Svezia 269
DE - Germania 228
HK - Hong Kong 134
FR - Francia 112
IN - India 100
RU - Federazione Russa 93
ZA - Sudafrica 74
IE - Irlanda 68
BR - Brasile 55
UA - Ucraina 48
JP - Giappone 42
TG - Togo 38
EE - Estonia 34
JO - Giordania 33
NL - Olanda 32
BD - Bangladesh 26
CH - Svizzera 22
FI - Finlandia 22
CI - Costa d'Avorio 21
KR - Corea 21
AT - Austria 20
IR - Iran 20
AR - Argentina 17
BG - Bulgaria 17
BE - Belgio 15
PL - Polonia 13
CA - Canada 12
CL - Cile 11
SC - Seychelles 11
TR - Turchia 10
PH - Filippine 9
PK - Pakistan 9
SA - Arabia Saudita 9
TH - Thailandia 9
ID - Indonesia 8
ES - Italia 6
NG - Nigeria 6
RO - Romania 6
CO - Colombia 5
CZ - Repubblica Ceca 5
PT - Portogallo 5
UZ - Uzbekistan 5
EC - Ecuador 4
LB - Libano 4
MX - Messico 4
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
IQ - Iraq 3
MA - Marocco 3
TW - Taiwan 3
AU - Australia 2
LT - Lituania 2
MY - Malesia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GI - Gibilterra 1
GM - Gambi 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
UG - Uganda 1
UY - Uruguay 1
ZM - Zambia 1
Totale 7.143
Città #
Singapore 451
Southend 375
Ashburn 330
Fairfield 267
Chandler 180
Dong Ket 173
Houston 169
Woodbridge 151
Bologna 140
Wilmington 138
San Jose 132
Hong Kong 128
Seattle 127
Santa Clara 116
Ann Arbor 105
Ho Chi Minh City 104
Cambridge 88
Princeton 79
Hanoi 74
Dublin 68
Beijing 64
Boardman 56
Dallas 52
New York 47
Hefei 45
Lauterbourg 41
Los Angeles 41
Nanjing 40
Westminster 40
Lomé 38
Padova 35
Amman 33
Johannesburg 31
Tokyo 28
Frankfurt am Main 27
Berlin 23
Abidjan 21
Bremen 21
Jinan 21
Shenyang 21
Bern 20
Changsha 20
Jacksonville 19
Helsinki 18
Saint Petersburg 18
Redondo Beach 17
Sofia 17
Council Bluffs 16
Seoul 15
Brussels 14
Nanchang 14
Turin 14
Vienna 14
Buffalo 13
Da Nang 13
Falls Church 13
Guangzhou 13
Haiphong 12
The Dalles 12
Florence 11
Hangzhou 11
Medford 11
Rome 11
Zhengzhou 11
Chicago 10
Haikou 10
London 10
Norwalk 10
Redmond 10
San Diego 10
Hebei 9
San Francisco 9
Tianjin 9
Orem 8
Shanghai 8
Amsterdam 7
Dearborn 7
Munich 7
Mülheim 7
Nuremberg 7
Pune 7
Abeokuta 6
Atlanta 6
Falkenstein 6
Fuzhou 6
Jiaxing 6
Ningbo 6
São Paulo 6
Warsaw 6
Washington 6
Bengaluru 5
Biên Hòa 5
Hải Dương 5
Ninh Bình 5
Parma 5
Phoenix 5
Redwood City 5
Toronto 5
Andover 4
Ankara 4
Totale 4.714
Nome #
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 263
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 259
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device 242
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 240
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 222
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 221
Therapeutic targeting of CK2 in acute and chronic leukemias. 220
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 212
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. 209
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 206
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 205
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 204
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 200
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 198
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 192
Drug discovery targeting the mTOR pathway 191
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 190
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 180
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 176
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 172
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 171
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 170
Compact and very high dose-rate plasma focus radiation sources for medical applications 167
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes 163
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 163
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 162
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 158
Nuclear phosphoinositides and their roles in cell biology and disease. 156
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications 155
Diet modulation restores autophagic flux in damaged skeletal muscle cells. 148
Marine bisindole alkaloid: a potential apoptotic inducer in cancer cells. 146
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 133
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 133
GSK-3β: a key regulator of breast cancer drug resistance 132
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 124
EVALUATION OF THE EFFICACY AND ANTITUMOR ACTIVITY OF THE PAN-CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITOR NVP-BKM120 IN HUMAN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) 113
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells 113
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status 113
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 101
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 97
null 95
HNE protein adducts and apoptosis in osteosarcoma cells 69
Tyrosol prevents apoptosis in irradiated keratinocytes. 59
null 43
Totale 7.286
Categoria #
all - tutte 18.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021266 0 0 0 0 0 0 0 0 0 0 0 266
2021/2022947 148 19 61 59 78 48 19 61 33 126 180 115
2022/2023855 78 119 48 131 55 61 29 42 166 9 71 46
2023/2024261 18 34 25 25 26 89 5 9 7 11 7 5
2024/2025801 15 111 81 63 177 42 56 27 1 58 33 137
2025/20262.126 183 149 190 124 250 155 257 120 436 180 80 2
Totale 7.286